Stock Analysis on Net

Humana Inc. (NYSE:HUM)

This company has been moved to the archive! The financial data has not been updated since October 30, 2024.

Enterprise Value (EV) 

Microsoft Excel

Current Enterprise Value (EV)

Humana Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $266.32
No. shares of common stock outstanding 120,411,343
US$ in millions
Common equity (market value)1 32,068
Add: Preferred stock, $1 par; none issued (per books)
Add: Noncontrolling interests (per books) 56
Total equity 32,124
Add: Book overdraft (per books) 353
Add: Short-term debt (per books) 1,443
Add: Long-term debt (per books) 10,213
Total equity and debt 44,133
Less: Cash and cash equivalents 4,694
Less: Investment securities 16,626
Enterprise value (EV) 22,813

Based on: 10-K (reporting date: 2023-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 266.32 × 120,411,343


Historical Enterprise Value (EV)

Humana Inc., EV calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Share price1, 2 $363.98 $505.69 $424.71 $378.33 $370.99
No. shares of common stock outstanding1 120,653,315 124,974,862 126,633,599 128,861,929 132,106,497
US$ in millions
Common equity (market value)3 43,915 63,199 53,783 48,752 49,010
Add: Preferred stock, $1 par; none issued (book value)
Add: Noncontrolling interests (book value) 56 59 23
Total equity 43,971 63,258 53,806 48,752 49,010
Add: Book overdraft (book value) 353 298 326 320 225
Add: Short-term debt (book value) 1,443 2,092 1,953 600 699
Add: Long-term debt (book value) 10,213 9,034 10,541 6,060 4,967
Total equity and debt 55,980 74,682 66,626 55,732 54,901
Less: Cash and cash equivalents 4,694 5,061 3,394 4,673 4,054
Less: Investment securities 16,626 13,881 13,192 12,554 10,972
Enterprise value (EV) 34,660 55,740 50,040 38,505 39,875

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Humana Inc. Annual Report.

3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 363.98 × 120,653,315


The financial data reveals notable trends over the five-year period ending December 31, 2023, across key equity and enterprise value measures.

Common equity (market value)
This metric remained relatively stable from 2019 to 2020, with a slight decrease from 49,010 million USD to 48,752 million USD. It then demonstrated growth in 2021 and 2022, reaching a peak of 63,199 million USD before declining significantly in 2023 to 43,915 million USD. The sharp drop in the final year represents a notable reversal from the preceding upward trend.
Total equity
Total equity trends closely mirror the common equity market value, beginning at 49,010 million USD in 2019 and decreasing marginally in 2020. Subsequent years showed increases to 53,806 million USD in 2021 and 63,258 million USD in 2022. However, the 2023 figure dropped to 43,971 million USD, reflecting a significant contraction in the company's equity position consistent with market value declines.
Total equity and debt
This combined measure of financing resources showed steady growth from 54,901 million USD in 2019 to a peak of 74,682 million USD in 2022, indicating an expanding capital base fueled by equity and/or debt increases. In 2023, however, there was a notable reduction to 55,980 million USD, suggesting a downsizing of the company’s overall capital structure during that period.
Enterprise value (EV)
Following a similar pattern, the enterprise value decreased from 39,875 million USD in 2019 to 38,505 million USD in 2020, before rising substantially to 50,040 million USD in 2021 and 55,740 million USD in 2022. In 2023, enterprise value dropped sharply to 34,660 million USD, underscoring a significant decline in the market’s valuation of the company when considering both equity and debt.

Overall, the data indicates a period of growth in equity and enterprise value between 2020 and 2022, followed by a pronounced decline in 2023. This suggests that the company experienced a contraction in market valuation and capital structure during the latest year, reversing earlier positive trends. The consistency across various measures implies that both equity markets and credit perspectives have shifted negatively toward the company in 2023.